← Scoopfeeds — Intelligent news, curated.
Why Canaccord Reduced Prestige Consumer Healthcare Inc. (PBH) Price Target After Q4 Weakness
business

Why Canaccord Reduced Prestige Consumer Healthcare Inc. (PBH) Price Target After Q4 Weakness

Yahoo Finance · Jun 2, 2026, 2:10 PM · Also reported by 4 other sources

Why Canaccord Reduced Prestige Consumer Healthcare Inc. (PBH) Price Target After Q4 Weakness

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Veracyte stock price target maintained at $42 by Canaccord on study results Investing.com Canaccord raises Waldencast stock price target on Obagi sale Investing.com UBS raises Caterpillar stock price target to $900 on strong Q1 beat Investing.com Freedom Broker raises i-80 Gold stock price target on stronger Q1

More in business

Decrypt
Anthropic Expands Access to Claude Mythos After AI Giant Files for IPO
CoinDesk
Gary Vaynerchuk says AI is creating the biggest opportunity ever for entrepreneurs
Investing.com
Euro’s global role stays flat despite US policy uncertainty
Investing.com
Fidelity China Special Situations appoints Bessie Lee to board
Investing.com
Form 144 ATI INC For: 2 June
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop